The International Medical Device Regulators Forum (IMDRF) has released a draft technical document to create a harmonized set ...

In the past 18 months, the FDA has outlined clear guidelines for designing, documenting, updating, and monitoring AI-powered ...

Nathan Eddy works as an independent filmmaker and journalist based in Berlin, specializing in architecture, business technology and healthcare IT. He is a graduate of Northwestern University’s Medill ...

Abbott Laboratories (ABT) reports steady earnings with robust growth in medical devices, while navigating challenges in diagnostics and nutrition segments.

The course offers key opportunities in understanding U.S. medical device approval pathways, including 510(k), IDE, PMA, and De Novo. It enhances practical skills through interactive case studies and ...

The EU will launch a pilot programme in 2026 to accelerate access to breakthrough medical devices and in vitro diagnostics ...

Johnson & Johnson’s immunology bet is paying off as the drugmaker gears up to market an innovative new psoriasis pill and had ...

Abbott today posted first-quarter financial results that came in ahead of the consensus sales forecast on Wall Street.

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

Abbott is dealing with integrating a big new buyout into its business alongside a weaker-than-expected respiratory disease ...

European authorities have recommended changes to the regulatory framework to keep pace with the progress of the ...

Abbott Laboratories ( ABT +1.49%) more or less met analyst estimates in its first quarter, the results of which were ...